Our Vision : We have High Standards - We Build Companies - We have Impact Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on therapeutic (current active fund KBIII) and Kurma Diagnostics focused on diagnostic and digital health (current active fund Kurma Dx2). Biotechnology, Lifesciences, Drug Development, Technology transfer, Rare diseases, Digital Healh, Diagnostics, and Medtech

Sectors: Startup accelerator & VC

Eurazeo is a leading global investment group Eurazeo is a leading global investment company, with a diversified portfolio of €34.1 billion in assets under management, including nearly €24.1 billion from third parties, invested in 590 companies. With its considerable private equity, private debt as well as real estate and infrastructure asset expertise, Eurazeo accompanies companies of all sizes, supporting their development through the commitment of its nearly 410 professionals and by offering deep sector expertise, a gateway to global markets, and a responsible and stable foothold for transformational growth. Its solid institutional and family shareholder base, robust financial structure free …

Sectors: Finance

Sofinnova Partners is a leading European VC firm in life sciences, specializing in healthcare and sustainability. Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise. Sofinnova Partners is a hands-on company builder across the entire value chain of life sciences investments, from seed to later-stage. The firm actively partners with ambitious entrepreneurs as a lead or cornerstone investor to develop transformative innovations that have the potential …

[Automatic translation follows] Pouss@LYS, the Lyon-Saint-Etienne territory consortium, sources, analyzes and labels #DeepTech #HighTech startups The Pouss@LYS consortium is made up of 27 structures from the research world of the Lyon-St Etienne site as well as players capable of detecting and qualifying technological startups (competitiveness clusters, incubators, accelerators, corporate programs, investment funds). These specialized business providers source, analyze and label startups, thus opening up almost automatic financing for them. The supported startups will be able to benefit, after the files have been examined by Bpifrance, from an investment by the French Tech Seed fund in addition to fundraising from qualified …

The health innovation network As a French leading biocluster, Lyonbiopole Auvergne-Rhône-Alpes aims to federate the actors of innovation, to connect and promote them internationally and to support the emergence and development of innovative technologies, products and services to address global healthcare challenges. Lyonbiopole Auvergne-Rhône-Alpes gathers a community of more than 250 members among which world-class leaders, innovative small and medium size companies, research centers and university hospitals. At the center of this ecosystem, Lyonbiopole brings its members altogether to imagine the future of medicine and to develop breakthrough healthTech innovation available for tomorrow’s patients.

Sectors: Biotechnology French Cluster Public business cluster

L'Agence économique régionale au service des entreprises industrielles et de services à l'industrie The Regional Economic Agency guides and supports industrial companies and services to industry businesses at all stages of their development: investment, training and employment, innovation, export, access to funding and European projects, etc. Auvergne-Rhône-Alpes Entreprises is also in charge of promoting the Auvergne-Rhône-Alpes region throughout the world and championing its multiple assets to attract new businesses. Valoriser, Structurer, and Accompagner

Sectors: National and local authorities

Entrepreneurs in HealthTech Created in 1997, the association is the French non-profit organization that brings together the country's leading innovative health compagnies and their expert partners (investors, lawyers, research institutes, cluster, etc...). Its core mission is to promote health innovation in France and help the sector's start-up companies and SMEs to become tomorrow's leaders able to rapidly develop new therapeutic solutions. Our Missions: To support innovative start-ups and SMEs of the HealthTech industry (biotech, medtech, digital health, big data) by tackling four major issues: - Financial: encourage investment in health innovation - Tax: ensure fiscal stability - Administrative and regulatory: …

Sectors: Biotechnology Startup accelerator & VC

[Automatic translation follows] A collective at the service of startups in Lyon and Saint-Étienne. The French Tech Saint-Étienne Lyon association promotes the creation, growth and internationalization of innovative companies in Lyon and Saint-Étienne startup, scaleup, innovation, and French Tech

Sectors: French Tech

La French Tech désigne tous les acteurs de l’écosystème de start-up françaises, soutenus par la Mission French Tech. 🇫🇷 La French Tech est la marque déployée par l’Etat français qui représente l’écosystème de 25 000 start-up françaises et de tous les acteurs qui gravitent autour (fonds d’investissement, associations, acteurs publiques, etc.), soutenus par la Mission French Tech (administration rattachée à la Direction Générale des Entreprises, au sein du ministère de l’Economie, des Finances et de l'Industrie). Elle a pour mission d’accompagner le développement de l’écosystème French Tech, mouvement français des start-up technologiques innovantes, dans la lignée des priorités gouvernementales, à …

Sectors: Media

We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio Pharmaceutical, Biopharmaceutical, Innovation, Research and development, and Global business

Sectors: Pharmaceutical

Transforming Lives, Every Day. Alexion, AstraZeneca Rare Disease was created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. by AstraZeneca. For more than 30 years, Alexion’s mission has been to transform the lives of people affected by rare diseases through the development and delivery of innovative medicines, supportive technologies, and healthcare services. Dedicated to continuing its mission as part of AstraZeneca, Alexion recognizes that patients and caregivers are people first, and by understanding their experiences, Alexion is better able to serve their unique needs. Alexion’s pioneering legacy in rare disease is rooted in being the first to translate the complex …

Sectors: Biotechnology Pharmaceutical